SavedAdd your journal

Journals / Atatürk Üniversitesi Tıp Dergisi (Y. A. The Eurasian Journal of Medicine) / 1997 / Cilt: 29 - Sayı: 2

Lipid profile in the patients with colo-rectal cancer

Kolo-rektal kanserli hastalarda lipid profili

Cafer POLAT
Müfide Nuran AKÇAY
Durkaya ÖREN
İrfan ALTUNTAŞ
Ali KILIÇ
Önder ÖZCAN
Pages
460–463
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum triglyceride (p< 0.0001) and very low-density lipoprotein cholesterol (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:İn order to investigate lipid profile in colorectal cancer, this study was conducted in 46 patients with colorectal cancer-and in 46 healthy control subjects.
📊
Key Findings & Data:Serum total cholesterol level obtained in the patient group was lower than that of the control group, but the difference was not statistically significant (p>().()5).
💡
Conclusion & Impact:Serum triglyceride (p< 0.0001) and very low-density lipoprotein cholesterol (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

İn order to investigate lipid profile in colorectal cancer, this study was conducted in 46 patients with colorectal cancer-and in 46 healthy control subjects. Serum cholesterol, triglyceride, apolipopropein A-l and apolipopropein B, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and very low-density lipoprotein cholesterol levels were quantified in the patient and control group. Serum total cholesterol level obtained in the patient group was lower than that of the control group, but the difference was not statistically significant (p>().()5). Like this, serum apolipoprotein A-l anıl B concentrations obtained in the patient group were not different from those of the control group. Serum triglyceride (p< 0.0001) and very low-density lipoprotein cholesterol (p

Özet

Kolo-rektal kanserde lipid profilini incelemek amacıyla, 46 kolo-rektal kanserli hastada ve 46 sağlıklı kontrol vakasında serum kolesterol, trigliserid, apolipopropein A-l ve apolipopropein B, yüksek-dansiteli lipoprotein kolesterol, düşük-dansiteli lipoprotein kolesterol ve çok düşük-dansiteli lipoprotein kolesterol düzeyleri incelendi. Hasta grubuna ait serum total kolesterol seviyesi kontrol grubundakinden düşüktü, ancak farklılık istatistiksel olarak anlamlı değildi (p>0.05). Benzer şekilde her iki gruptaki serum apolipopropein A-l ve B seviyeleri arasında da farklılık yoktu. Hasta grubundaki serum trigliserid (p

🔖

Cite This Article

POLAT, C., AKÇAY, M. N., ÖREN, D., ALTUNTAŞ, İ., KILIÇ, A., ÖZCAN, Ö. (2022). Lipid profile in the patients with colo-rectal cancer. Atatürk Üniversitesi Tıp Dergisi (Y. A. The Eurasian Journal of Medicine), Cilt: 29 - Sayı: 2, 460–463. https://ajindex.com/articles/455086

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Neugut AI, Johnsen C.M, Fink D.J. Serum cholesterol levels in adenomatous polyps and cancer of the colon. JAMA 1986; 255: 365-367
  2. Neaton JD, Blackburn H, Jacobs D. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med 1992; 152: 1490-1500
  3. Mannes G.A, Maier A, Thieme C, Wiebecke B, Paumgartner G. Relation between the frequency of colorectal adenoma and the serum cholesterol level. N Engl J Med 1986; 315: 1634-1637
  4. Dessi S, Batetta B, Pulisci D. Cholesterol content in tumor tissues is inversely associated with high- density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 1994; 73: 253-258
  5. Broitman SA, Cerda S, Wilkinson J. Cholesterol metabolism and colon cancer. Prog Food Nutr Sci 1993; 17: 1-40. 6.metabolism during the growth of rat ascites hepatoma. Br J Cancer 1992; 66: 787-93
  6. Dessi S, Batetta B, Spano 0. Serum lipoproteins during bone morrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol 1990; 74: 671-5
  7. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature London 1990; 343: 425-30
  8. BayerdOrffer E, Mannes GA, Richter WA. Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann Int Med 1993; 118: 481-487
  9. Kreger BE, Anderson KM, Schatzkin A, Splansky SG. Serum cholesterol level, body mass index, and the risk of colon cancer. Cancer 1992; 70: 1038-1043
  10. Burnstein MJ. Dietary factors related to colorectal neoplasms. Surg Chu North Am 1993; 73: 13-26
  11. Tornberg SA, Holm LE, Carstensen JM, Eklund GA. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta- lipoprotein. N Engl J Med 1986; 315: 1629- 1633
  12. Frildewald WT, Ley RI, Frederickson DS. Estimation of the concentration of low density protein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
  13. Kritchevsky D, Tepper SA, Goodman G. Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Am J Clin Nutr 1984; 40: 921-926
  14. Chyou PH, Nomura AM, Stemmermann GN, Kato I. Prospective study of serum cholesterol and site-specific cancers. J Clin Epidemiol 1992; 45: 287-292.